Stocks to Watch: Levi Strauss, Ocuphire Pharma, Magenta Therapeutics, Las Vegas Sands, Seagate Technology
Sabela Ojea Levi Strauss & Co. said Wednesday that it expects revenue and earnings growth in 2023 after beating analysts expectations for the last quarter of 2022. Shares of the…